The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1b study of weekly split-dose selinexor in soft tissue sarcoma (STS).
 
Abdulazeez Salawu
No Relationships to Disclose
 
Abha A. Gupta
No Relationships to Disclose
 
Esmail Mutahar Al-Ezzi
No Relationships to Disclose
 
Sofia Genta
No Relationships to Disclose
 
Eoghan Ruadh Malone
No Relationships to Disclose
 
Tushar Shailesh Vora
No Relationships to Disclose
 
Geoffrey Alan Watson
Honoraria - Pfizer
Travel, Accommodations, Expenses - Abbvie
 
Olga Vornicova
Consulting or Advisory Role - Merck Serono; Novartis
Speakers' Bureau - BMS; Medison; MSD Oncology; Novartis
 
Lisa Wang
No Relationships to Disclose
 
Limore Arones
No Relationships to Disclose
 
Madeline J. Phillips
No Relationships to Disclose
 
Jasmine Lee
No Relationships to Disclose
 
Albiruni Ryan Abdul Razak
Consulting or Advisory Role - Adaptimmune; Bayer; GlaxoSmithKline; Inhibrx; Medison
Research Funding - Abbvie; Adaptimmune; Amgen; Blueprint Medicines; Bristol-Myers Squibb; Daiichi Sankyo; Deciphera; GlaxoSmithKline; Iterion Therapeutics; Karyopharm Therapeutics; MedImmune; Merck; Neoleukin Therapeutics; Pfizer; Rain Therapeutics; Roche/Genentech; Symphogen
Expert Testimony - Medison